The use of dose-escalated radiation for locally advanced non-small cell lung cancer in the U.S., 2004–2013
Open Access
- 17 January 2017
- journal article
- research article
- Published by Springer Nature in Radiation Oncology
- Vol. 12 (1) , 19
Abstract
The clinical effects of radiation dose-intensification in locally advanced non-small cell lung (NSCLCa) and other cancers are challenging to predict and are ideally studied in randomized trials. The purpose of this study was to assess the use of dose-escalated radiation for locally advanced NSCLCa in the U.S., 2004–2013, a period in which there were no published level 1 studies on dose-escalation. We performed analyses on two cancer registry databases with complementary strengths and weaknesses: the National Oncology Data Alliance (NODA) 2004–2013 and the National Cancer Database (NCDB) 2004–2012. We classified locally advanced patients according to the use of dose-escalation (>70 Gy). We used adjusted logistic regression to assess the association of year of treatment with dose-escalated radiation use in two periods representing time before and after the closure of a cooperative group trial (RTOG 0617) on dose-escalation: 2004–2010 and 2010–2013. To determine the year in which a significant change in dose could have been detected had dose been prospectively monitored within the NODA network, we compared the average annual radiation dose per year with the forecasted dose (average of the prior 3 years) adjusted for patient age and comorbidities. Within both the NODA and NCDB, use of dose-escalation increased from 2004 to 2010 (p < 0.0001) and decreased from 2010 to 2013 (p = 0.0018), even after controlling for potential confounders. Had the NODA network been monitoring radiation dose in this cohort, significant changes in average annual dose would have been detected at the end of 2008 and 2012. Patterns of radiation dosing in locally advanced NSCLCa changed in the U.S. in the absence of level 1 evidence. Monitoring radiation dose is feasible using an existing national cancer registry data collection infrastructure.Keywords
Funding Information
- no external funding (Not applicable)
This publication has 14 references indexed in Scilit:
- The hypoxic tumor microenvironment: A driving force for breast cancer progressionBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2016
- Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 studyThe Lancet Oncology, 2015
- Is Intermediate Radiation Dose Escalation With Concurrent Chemotherapy for Stage III Non–Small-Cell Lung Cancer Beneficial? A Multi-Institutional Propensity Score Matched AnalysisInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2015
- Patterns of practice in radiation therapy for non-small cell lung cancer among members of the American Society for Radiation OncologyPractical Radiation Oncology, 2014
- Radiation and immunotherapy: a synergistic combinationJournal of Clinical Investigation, 2013
- Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410JNCI: Journal of the National Cancer Institute, 2011
- A Phase I/II Radiation Dose Escalation Study With Concurrent Chemotherapy for Patients With Inoperable Stages I to III Non-Small-Cell Lung Cancer: Phase I Results of RTOG 0117International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non–small-cell lung cancer: Long-term results of a radiation dose escalation studyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Results of a phase I dose‐escalation study using three‐dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinomaCancer, 2005
- Survival and Failure Patterns of High-Grade Gliomas After Three-Dimensional Conformal RadiotherapyJournal of Clinical Oncology, 2002